Abstract
To the Editor, Walker and coauthors [5] recently reported on the effects of introducing a new clinical care pathway in the management of bronchiolitis in infants aged below 6 months. They observed a significant reduction in the use of salbutamol and ipratropium bromide, and an overall reduction in the duration of hospital stay while the prescription rate of antibiotics
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
